FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/11/076947 [Registered on: 18/11/2024] Trial Registered Prospectively
Last Modified On: 18/11/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Nitroglycerin Aloe Vera Gel for Angina 
Scientific Title of Study   Formulation and Evaluation of Nitroglycerin Aloe Vera Gel for Angina 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr. Imran Ahmad Khan 
Designation  Assistant Professor 
Affiliation  Muhammad Institute of Medical and Allied Sciences, Multan, Pakistan. 
Address  Multan



66000
Other 
Phone  03336120602  
Fax    
Email  imranahmadkhandurrani@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Imran Ahmad Khan 
Designation  Assistant Professor 
Affiliation  Department of Pharmacy, MNS University of Agriculture, Multan, Pakistan 
Address  Multan
Multan


66000
Other 
Phone  03336120602  
Fax    
Email  imranahmadkhandurrani@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Imran Ahmad Khan 
Designation  Assistant Professor 
Affiliation  Department of Pharmacy, MNS University of Agriculture, Multan, Pakistan 
Address  Multan
Multan


66000
Other 
Phone  03336120602  
Fax    
Email  imranahmadkhandurrani@gmail.com  
 
Source of Monetary or Material Support  
Student Research fund of Muhammad Institute of Medical and Allied Sciences, Multan,66000, Pakistan. 
 
Primary Sponsor  
Name  QuratUlAin 
Address  Muhammad Institute of Medical and Allied Sciences, Multan, Pakistan. 
Type of Sponsor  Other [Student fund] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     Pakistan  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr InamUrRehman  CPEIC Multan, a tertiary care hospital specializing in cardiac care.  Emergency department, ground floor, Building A

 
03126827130

dr.inam977@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Comitte Muhammad Institute of Medical and Allied Sciences Multan  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I999||Unspecified disorder of circulatory system,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nitroglycerin 6% Aloe Vera Gel   Route: Topically to the skin (e.g., chest or upper arms) Dose: measured dose of the nitroglycerin 6% aloe vera gel Frequency: once daily or during angina onset. 
Comparator Agent  SUBLINGUAL Nitroglycerine tab  Route: SUBLINGUAL Nitroglycerine tab will be given Frequency: 3 times a day Dose: 0.5 mg/tab Total duration: Depending on angina attacks recurrency 
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  • Patient at least 25-60-year-old.
• Patient with suspected s angina pectoris who undergo coronary angiography
• Breast feeding mothers
• Intestinal angina
• Hypertensive patient
• Abdominal infarction
• Pregnant female
 
 
ExclusionCriteria 
Details  • severe myocardial infarction
• Cardiogenic shock
• Severe heart faliure
• Hypersensitive to medicine
• Severe hypotension
• Cardiac temponade
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Efficacy of the 6% nitroglycerin aloe vera gel in relieving angina symptoms through topical administration.
To assess the safety and tolerability of the gel.
To compare the onset and duration of action of the gel with other forms of nitroglycerin (e.g., sublingual tablets).
To evaluate patient compliance and usability of the gel.
To measure improvements in quality of life in patients with chronic angina. 
baseline and after 4 hrs.
when angina settled 
 
Secondary Outcome  
Outcome  TimePoints 
Breathing pattern  Baseline & after 4 hrs 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="0" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   30/11/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  30/11/2024 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="10" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

We purchased Nitromint 2.6 mg tablet of Egis Pharmaceutical ltd. Hungary. I took Fresh aloevera leaves from plant and extracted the latex of aloevera 100 grams. I grinded 6.5 mg Nitro mint bypestle motor and added into 100 grams of aloevera gel mixed it with Robinson mixture for 15minutes per revolution under supervision of quality control test. This 6% nitroglycerin aloe vera gel is designed for topical application to patients with angina at CPEIC Multan. The gel will be applied to areas such as the chest or upper arms where it allows nitroglycerin to be absorbed through the skin producing vasodilation and increasing blood flow to the heart thereby relieving angina symptoms. Aloe vera contributes to skin soothing and healing reducing irritation at the application site. ECG monitors Pulse oximeter (lifecare:fingertip pulseoximeterchina) a thermometer (Hamilton company USA) a stethoscope and mercury manometer were used to record parameters like BP pulse rate blood pressure. Data will be composed after taking written informed consent 80 subjects meeting the eligibility criteria will be incorporated

 
Close